Synapse

← Translational and Clinical Pharmacology

Papers in Translational and Clinical Pharmacology

Page 1 · newest first

  1. Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health recordsTranslational and Clinical Pharmacology · 2026
  2. Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025Translational and Clinical Pharmacology · 2026
  3. Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016–2024)Translational and Clinical Pharmacology · 2026
  4. Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)Translational and Clinical Pharmacology · 2026
  5. Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover studyTranslational and Clinical Pharmacology · 2026
  6. The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lensTranslational and Clinical Pharmacology · 2026
  7. Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participantsTranslational and Clinical Pharmacology · 2026
  8. Development and evaluation of automated screening algorithms for pre-analytical errors in pharmacokinetic data: a simulation-based studyTranslational and Clinical Pharmacology · 2026
  9. Implementation of decentralized clinical trials in Korea from a resource-based perspectiveTranslational and Clinical Pharmacology · 2026
  10. Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participantsTranslational and Clinical Pharmacology · 2026
  11. The evolving landscape of inflammation-related clinical trials: a 25-year registry-based network analysis from a clinical pharmacology perspectiveTranslational and Clinical Pharmacology · 2026
  12. A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025Translational and Clinical Pharmacology · 2025
  13. Application of population pharmacokinetic modeling of SVG-101 to evaluate proper dose selectionTranslational and Clinical Pharmacology · 2025
  14. Clinical development of oral semaglutide for the treatment of type 2 diabetes mellitus: focusing on early phase clinical trialsTranslational and Clinical Pharmacology · 2025
  15. Insight and benefits from vaccine clinical trials with adaptive designs: a scoping reviewTranslational and Clinical Pharmacology · 2025
  16. Identification of biomarkers in gynecologic cancers: a machine learning approach for metabolomicsTranslational and Clinical Pharmacology · 2025
  17. Prediction of first-in-human dose for new composition bee venom based on allometric scaling and pharmacokinetic modeling approachTranslational and Clinical Pharmacology · 2025
  18. Comparative effectiveness of long-term anti-obesity medications in routine clinical practice: a retrospective cohort study using real-world dataTranslational and Clinical Pharmacology · 2025
  19. Serum IGF-1 and IGFBP-3 levels in healthy Korean men aged 19–40 years: a cross-sectional analysis of reference ranges and seasonal variationTranslational and Clinical Pharmacology · 2025
  20. Acid-suppressive effect of tegoprazan 12.5 mg BID: a phase 1 comparative study with tegoprazan 25 mg QD and famotidine 20 mg BIDTranslational and Clinical Pharmacology · 2025
  21. Association between the difference in creatinine-based and creatinine-cystatin C-based estimated glomerular filtration rates and vancomycin systemic exposure after ventricular assist device surgeryTranslational and Clinical Pharmacology · 2025
  22. Web-based automated therapeutic drug monitoring application for precision medicine in tuberculosis managementTranslational and Clinical Pharmacology · 2025
  23. Quantitation of methotrexate polyglutamates in red blood cells and application in patients with Crohn’s diseaseTranslational and Clinical Pharmacology · 2025
  24. Comparison of pharmacokinetics of a fixed-dose combination of atorvastatin/ezetimibe 5 mg/10 mg versus separate tablets in healthy subjectsTranslational and Clinical Pharmacology · 2025
  25. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidanceTranslational and Clinical Pharmacology · 2024
  26. Data science through natural language with ChatGPT’s Code InterpreterTranslational and Clinical Pharmacology · 2024
  27. Development of in-silico drug cardiac toxicity evaluation system with consideration of inter-individual variabilityTranslational and Clinical Pharmacology · 2024
  28. Cardiotoxicity evaluation of two-drug fixed-dose combination therapy under CiPA: a computational studyTranslational and Clinical Pharmacology · 2024
  29. Advanced clinical symptoms of the antihangover compound HK-GCM-H01 in healthy KoreansTranslational and Clinical Pharmacology · 2024
  30. The effects of opium consumption on severity of disease on hospitalized COVID-19 patients in East of Iran, a prospective cohort studyTranslational and Clinical Pharmacology · 2024
  31. Analyzing collaborations in clinical trials in Korea using association rule miningTranslational and Clinical Pharmacology · 2024
  32. Exploration of pharmacokinetic differences between East Asians and Caucasians: insights from pharmacokinetic studies in healthy subjectsTranslational and Clinical Pharmacology · 2024
  33. Emerging and upcoming therapies in insomniaTranslational and Clinical Pharmacology · 2024
  34. Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomized-sequence, 2-period crossover studyTranslational and Clinical Pharmacology · 2024
  35. Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect modelTranslational and Clinical Pharmacology · 2024
  36. PMDA initiatives to enhance drug development via multi-regional clinical trialsTranslational and Clinical Pharmacology · 2024
  37. Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjectsTranslational and Clinical Pharmacology · 2024
  38. Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trialsTranslational and Clinical Pharmacology · 2024
  39. Determination of a robust headspace GC-MS/MS method for analysis of ethyl alcohol and acetaldehyde: clinical application to pharmacokinetics studyTranslational and Clinical Pharmacology · 2024
  40. A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapyTranslational and Clinical Pharmacology · 2023
  41. Transforming clinical trials: the emerging roles of large language modelsTranslational and Clinical Pharmacology · 2023
  42. Effects of three-dimensional image based insole for healthy volunteers: a pilot clinical trialTranslational and Clinical Pharmacology · 2023
  43. Impact of antioxidants in improving semen parameters like count, motility and DNA fragmentation in sub-fertile males: a randomized, double-blind, placebo-controlled clinical trialTranslational and Clinical Pharmacology · 2023
  44. Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteersTranslational and Clinical Pharmacology · 2023
  45. Efficacy and safety assessment of protein supplement - micronutrient fortification in promoting health and wellbeing in healthy adults - a randomized placebo-controlled trialTranslational and Clinical Pharmacology · 2023
  46. Adaptive design clinical trials: current status by disease and trial phase in various perspectivesTranslational and Clinical Pharmacology · 2023
  47. Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertensionTranslational and Clinical Pharmacology · 2023
  48. Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjectsTranslational and Clinical Pharmacology · 2023
  49. Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjectsTranslational and Clinical Pharmacology · 2023
  50. Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal functionTranslational and Clinical Pharmacology · 2023